RenovoRx, Inc.
RNXT
$0.86
-$0.03-2.89%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.49M | 1.12M | 928.00K | 662.00K | 240.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.49M | 1.12M | 928.00K | 662.00K | 240.00K |
| Cost of Revenue | 317.00K | 327.00K | 299.00K | 246.00K | 94.00K |
| Gross Profit | 1.17M | 796.00K | 629.00K | 416.00K | 146.00K |
| SG&A Expenses | 8.20M | 7.05M | 5.92M | 5.37M | 5.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.86M | 13.13M | 12.55M | 11.91M | 11.84M |
| Operating Income | -12.37M | -12.01M | -11.62M | -11.25M | -11.60M |
| Income Before Tax | -12.27M | -11.17M | -11.11M | -10.66M | -10.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.27 | -11.17 | -11.11 | -10.66 | -10.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.27M | -11.17M | -11.11M | -10.66M | -10.16M |
| EBIT | -12.37M | -12.01M | -11.62M | -11.25M | -11.60M |
| EBITDA | -12.37M | -12.01M | -8.99M | -5.79M | -3.11M |
| EPS Basic | -0.33 | -0.32 | -0.35 | -0.37 | -0.39 |
| Normalized Basic EPS | -0.20 | -0.19 | -0.22 | -0.23 | -0.24 |
| EPS Diluted | -0.33 | -0.32 | -0.35 | -0.37 | -0.39 |
| Normalized Diluted EPS | -0.20 | -0.19 | -0.22 | -0.23 | -0.24 |
| Average Basic Shares Outstanding | 147.91M | 141.27M | 129.73M | 118.02M | 105.49M |
| Average Diluted Shares Outstanding | 147.91M | 141.27M | 129.73M | 118.02M | 105.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |